Free Trial

Anteris Technologies Global Corp's Quiet Period Will End on January 22nd (NASDAQ:AVR)

Anteris Technologies Global logo

Anteris Technologies Global's (NASDAQ:AVR - Get Free Report) quiet period will expire on Wednesday, January 22nd. Anteris Technologies Global had issued 14,800,000 shares in its IPO on December 13th. The total size of the offering was $88,800,000 based on an initial share price of $6.00. During Anteris Technologies Global's quiet period, insiders and underwriters that worked on the IPO are prevented from issuing any research reports for the company because of SEC regulations. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Analyst Ratings Changes

A number of equities research analysts have commented on AVR shares. Barclays initiated coverage on Anteris Technologies Global in a report on Tuesday, January 7th. They set an "overweight" rating and a $22.00 price target on the stock. Cantor Fitzgerald started coverage on shares of Anteris Technologies Global in a research note on Tuesday, January 7th. They set an "overweight" rating and a $9.00 price target on the stock. Lake Street Capital began coverage on shares of Anteris Technologies Global in a report on Wednesday, January 8th. They issued a "buy" rating and a $20.00 target price on the stock. Finally, TD Cowen initiated coverage on shares of Anteris Technologies Global in a report on Tuesday, January 7th. They issued a "buy" rating and a $15.00 price target for the company.

Read Our Latest Research Report on Anteris Technologies Global

Anteris Technologies Global Stock Performance

NASDAQ:AVR traded up $0.26 during midday trading on Wednesday, hitting $5.87. 62,230 shares of the company traded hands, compared to its average volume of 152,214. Anteris Technologies Global has a 12-month low of $5.10 and a 12-month high of $6.10.

Anteris Technologies Global Company Profile

(Get Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

See Also

Should You Invest $1,000 in Anteris Technologies Global Right Now?

Before you consider Anteris Technologies Global, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anteris Technologies Global wasn't on the list.

While Anteris Technologies Global currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Nuclear energy is making a resurgence! Watch to find out which seven nuclear energy stocks could deliver long-term gains in the transition to cleaner energy.

Related Videos

Pelosi Bets Big on AI: Her Top 5 Stock Picks
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines